To complete, or not to complete, that is the question of revascularization in percutaneous coronary intervention with drug-eluting stents for multivessel disease

In patients with multivessel (MV) coronary artery disease (CAD) (MV-CAD) except for acute myocardial infarction (acute MI, AMI) [including acute ST-segment elevation MI (STEMI)], the clinical impact of completeness of revascularization (RV) in percutaneous coronary intervention (PCI) with drug-eluting stents (DES) (DES-PCI) on major adverse cardiac (and cerebrovascular) events [MAC(C)E] remains unclear.